Table 5. Cardiovascular screening history before starting pharmacotherapy.
| Screening parameters | Screening history |
|---|---|
| Symptoms* | Unusual fatigue associated with physical activity (more than or different from others) |
| Pain, discomfort, or pressure in chest during exercise | |
| Pre-syncope or syncope during or after exercise, emotion, or startle | |
| Dizziness associated with exercise | |
| Shortness of breath associated with exercise (more than or different from others) | |
| Heart racing or skipped beats | |
| Medical history and review of systems | Unexplained seizures* |
| Detailed history of any congenital structural heart disease* | |
| Use of cardiac pacemaker or implanted cardiac defibrillator* | |
| History of Kawasaki disease* | |
| History of rheumatic fever*—known heart murmur | |
| Systemic hypertension | |
| Substance abuse, tobacco use | |
| Use of excessive caffeine or energy drinks | |
| Any previous recommendations to restrict physical activity | |
| Family history* | Sudden or unexpected death of family members before age 50 years |
| Coronary artery disease before age 50 years | |
| Family members using pacemaker or implanted cardiac defibrillator | |
| Family history of cardiomyopathies, long QT syndrome, short QT syndrome, or Brugada syndrome | |
| Family history of primary pulmonary hypertension |
*, positive screening should warrant further cardiac evaluation.